Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Peritoneal+Cavity%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
/vufind/Search/Results?lookfor=%22Peritoneal+Cavity%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
Search /vufind/Search2/Results?lookfor=%22Peritoneal+Cavity%22&type=Subject&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22
PubPharm (34)
1
Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer : Evaluation of the Immunogenicity of Vaccination With Synthetic Peptides in Adjuvant in Patients With Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer : Clinical Phase II Study Evaluating Systemic Chemotherapy in Combination With Cetuximab as Adjuvant Treatment in Patients With Completely Surgically Resected Peritoneal Carcinomatosis of Colorectal Origin
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
3
Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer : Phase II Trial of Weekly Gemcitabine and Docetaxel Combination Therapy for Relapsed Ovarian or Peritoneal Cancer
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
4
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer : A Phase II Evaluation of CCI-779 (Temsirolimus, NCI-Supplied Agent, NSC #683864, IND #61010) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
5
Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin : A Phase II Evaluation of Belinostat (NSC #726630) and Carboplatin (NSC #241240) in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
6
Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer : A Phase II Evaluation of Enzastaurin (Lilly IND # 60, 933) in the Treatment of Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
7
Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer : A Phase 2 Study of AZD2171 in Recurrent or Persistent Ovarian, Peritoneal, or Fallopian Tube Cancer
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
8
Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer : A Phase II Evaluation of Mifepristone in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
9
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer : A Phase II Evaluation of Docetaxel (NSC #628503) Plus Trabectedin (Yondelis®), R279741, IND # 101018) With Growth Factor Support in the Third-Line Treatment of Recurrent or Persistent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
10
Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix : A Multi-Center, Open-Label, Randomized Phase II Trial to Evaluate Hematologic Toxicities After HIPEC With Oxaliplatin or Mitomycin C in Patients With Appendiceal Tumors
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
1
2
3
4
Nächster »
[4]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
34
Aufsätze
34
E-Artikel
34
E-Ressourcen
Zeitschriftentitel
34
ClinicalTrials.gov
Thema
34
610
Phase: Phase 2
34
Study Type: Interventional
26
Fallopian Tube Neoplasms
18
Recruitment Status: Completed
15
Carcinoma, Ovarian Epithelial
12
Peritoneal Neoplasms
12
Recruitment Status: Terminated
9
Medical Condition: Fallopian Tube Cancer, Ovari...
8
Medical Condition: Fallopian Tube Cancer, Ovari...
8
Ovarian Neoplasms
4
Carcinoma
3
Adenocarcinoma
3
Medical Condition: Ovarian Cancer, Peritoneal C...
3
Recruitment Status: Unknown status
2
Brenner Tumor
2
Carcinoma, Endometrioid
2
Cystadenocarcinoma
2
Cystadenocarcinoma, Mucinous
2
Cystadenocarcinoma, Serous
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2020-
31
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
34
Englisch
Haven't found what you're looking for?
Wird geladen...